These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Ribeiro JA Eur J Pharmacol; 1999 Jun; 375(1-3):101-13. PubMed ID: 10443568 [TBL] [Abstract][Full Text] [Related]
3. Adenosine A2 receptor-mediated excitatory actions on the nervous system. Sebastião AM; Ribeiro JA Prog Neurobiol; 1996 Feb; 48(3):167-89. PubMed ID: 8735876 [TBL] [Abstract][Full Text] [Related]
4. Purinergic regulation of acetylcholine release. Ribeiro JA; Cunha RA; Correia-de-Sá P; Sebastião AM Prog Brain Res; 1996; 109():231-41. PubMed ID: 9009712 [TBL] [Abstract][Full Text] [Related]
5. Interactions between adenosine and metabotropic glutamate receptors in the rat hippocampal slice. Shahraki A; Stone TW Br J Pharmacol; 2003 Mar; 138(6):1059-68. PubMed ID: 12684261 [TBL] [Abstract][Full Text] [Related]
6. Potentiation by tonic A2a-adenosine receptor activation of CGRP-facilitated [3H]-ACh release from rat motor nerve endings. Correia-de-Sá P; Ribeiro JA Br J Pharmacol; 1994 Feb; 111(2):582-8. PubMed ID: 8004402 [TBL] [Abstract][Full Text] [Related]
7. A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Latini S; Pazzagli M; Pepeu G; Pedata F Gen Pharmacol; 1996 Sep; 27(6):925-33. PubMed ID: 8909972 [TBL] [Abstract][Full Text] [Related]
9. Participation of adenosine receptors in neuroprotection. Ribeiro JA; Sebastiao AM; de Mendonca A Drug News Perspect; 2003 Mar; 16(2):80-6. PubMed ID: 12792668 [TBL] [Abstract][Full Text] [Related]
10. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? von Lubitz DK Eur J Pharmacol; 1999 Apr; 371(1):85-102. PubMed ID: 10355598 [TBL] [Abstract][Full Text] [Related]
11. Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Guieu R; Dussol B; Halimi G; Bechis G; Sampieri F; Berland Y; Sampol J; Couraud F; Rochat H Gen Pharmacol; 1998 Oct; 31(4):553-61. PubMed ID: 9792214 [TBL] [Abstract][Full Text] [Related]
12. The role and regulation of adenosine in the central nervous system. Dunwiddie TV; Masino SA Annu Rev Neurosci; 2001; 24():31-55. PubMed ID: 11283304 [TBL] [Abstract][Full Text] [Related]
13. Adenosine A1 and class II metabotropic glutamate receptors mediate shared presynaptic inhibition of retinotectal transmission. Zhang C; Schmidt JT J Neurophysiol; 1999 Dec; 82(6):2947-55. PubMed ID: 10601431 [TBL] [Abstract][Full Text] [Related]
14. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine receptors in the rat hippocampus. Morton RA; Davies CH J Physiol; 1997 Jul; 502 ( Pt 1)(Pt 1):75-90. PubMed ID: 9234198 [TBL] [Abstract][Full Text] [Related]
18. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Cunha RA Neurochem Int; 2001 Feb; 38(2):107-25. PubMed ID: 11137880 [TBL] [Abstract][Full Text] [Related]
19. [Adenosine and homeostatic control of sleep. Actions in target structures of the sleep-wake circuits]. Carús-Cadavieco M; de Andrés I Rev Neurol; 2012 Oct; 55(7):413-20. PubMed ID: 23011860 [TBL] [Abstract][Full Text] [Related]
20. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Abbracchio MP; Cattabeni F Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]